Diabetes Self-management With Continuous Glucose Monitoring
ConditionType 1 Diabetes
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorNordsjaellands Hospital
About this trial
The overall goal of this observational study is to investigate the interaction between people with type 1 diabetes and continuous glucose monitoring (CGM) and the impact of this interaction on quality of life, particularly the level of diabetes distress, and glycaemic metrics.
Participants will:
* Visit the clinic twice with a 14-day interval * Fill out a survey before the first and at the last visit * Use CGM as usual and use smart insulin pens and an activity tracker * Register food intake * Answer two-three questions twice a day in REDCap
Eligibility criteria
Qualifiers
Age between 18 and 85 years.
Diagnosed with T1D over one year ago.
Actively using FreeStyle Libre 2 (>80% sensor activity).
Used FreeStyle Libre 2 for over three months.
Disqualifiers
History of allergic reactions to materials or adhesives used in CGM devices.
Presence of severe cognitive or psychiatric conditions that could hinder the effective use of CGM or smart caps or pens - at the investigator's discretion.
Current use of steroids unless part of a chronic therapy plan.
Daily consumption of vitamin C ≥ 500 mg.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Nordsjaellands Hospital
Lead sponsor
Steno Diabetes Center Copenhagen
Collaborator
Source ClinicalTrials.gov